knowledge -WSS

knowledge

author：explore 2025-09-28 02:33:12 - browse：7

Cheryl Meier had watched clinical trial enrollment announcements for years — but always for her sons’ type 1 diabetes, never for herself. Her OB-GYN had put her on Effexor for her depression 20 years ago, and it worked well enough — she could sleep for the first time in her life, and she no longer cried at every little thing. But it never worked for her dark thoughts.

But then she retired, and then she had time, and then she saw an email — “I guess once your name gets on a list, it’s there,” she said — for an experimental depression drug called zuranolone.

Unlike today’s crowded market of SSRIs, prescribed once and taken for months, years, or even indefinitely, zuranolone, developed by Sage Therapeutics, promises something different.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： In Memoriam: Notable people who died in 2023
Next article： Contact tracing may help avoid another lockdown. Can it work in the U.S.?

entertainment

knowledge

WSS

Dogs on Prozac: What pet anti

Organ transplantation is at a crossroads. Major reform is needed

After traumatic brain injury, life support decisions can use more time

Getting Alzheimer's drug Leqembi to patients can be a challenge

Russian special forces kill a gunman who broke into a private house near Moscow

FTC falls short on scrutinizing hospital mergers, study says

hotspot

knowledge

entertainment

Malaria cases in Florida and Texas: Here’s what you need to know

How artificial intelligence is being used to detect, treat cancer

Medical records are filled with copy

Melinda French Gates resigns from Gates Foundation

Malaria cases in Florida and Texas: Here’s what you need to know

Vatican is moving ahead with plan to reunite Ukrainian children taken to Russia with their families

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

Element Biosciences CEO lays out genome sequencing strategy

New air purifier tech could be key to improving indoor air quality

After traumatic brain injury, life support decisions can use more time

entertainment

Why rehabilitation engineers need to center patients in their research

Diversity in clinical trials starts with building trust, experts say

Vatican is moving ahead with plan to reunite Ukrainian children taken to Russia with their families

Element Biosciences CEO lays out genome sequencing strategy

Caitlin Bernard's story shows physicians can't shy from advocacy

Russian special forces kill a gunman who broke into a private house near Moscow

entertainment

explore

knowledge

Wikipedia